Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care
Ann Surg Oncol
.
2022 Sep;29(9):5344-5346.
doi: 10.1245/s10434-022-11915-4.
Epub 2022 May 27.
Author
Jessica S Donington
1
Affiliation
1
Section of Thoracic Surgery, University of Chicago Medicine, Chicago, IL, USA. jdonington@uchicago.edu.
PMID:
35622177
DOI:
10.1245/s10434-022-11915-4
No abstract available
Publication types
Editorial
MeSH terms
Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / therapy
Humans
Immunotherapy
Lung Neoplasms* / pathology
Lung Neoplasms* / therapy
Neoadjuvant Therapy
Neoplasm Staging